StockData
Neuronetics, Inc. logo

Neuronetics, Inc. (STIM) stock

STIMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30
$1.28+0.03 (+2.40%)

Close on Nov 17, 2026Market cap $97.53MP/E –Yield –

Neuronetics r&d expenses

Research and development expenses are spending on new products and technology.

Neuronetics's R&D Expenses for the twelve months ending Jun 30, 2026 was $5.87M, down 49.4% year over year. For fiscal 2025 it was $6.58M, down 48.4% from the year before. The highest annual figure on record is $13.75M in fiscal 2019.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$6.58M-48.4%
FY2024Dec 31, 2024$12.77M+34.2%
FY2023Dec 31, 2023$9.52M+1.9%
FY2022Dec 31, 2022$9.34M+17.8%
FY2021Dec 31, 2021$7.92M-13.9%
FY2020Dec 31, 2020$9.20M-33.1%
FY2019Dec 31, 2019$13.75M+67.0%
FY2018Dec 31, 2018$8.23M+3.7%
FY2017Dec 31, 2017$7.94M-3.5%
FY2016Dec 31, 2016$8.22M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.34M-25.7%
Q1 FY2026Mar 31, 2026$1.36M-15.6%
Q4 FY2025Dec 31, 2025$1.67M-71.1%
Q3 FY2025Sep 30, 2025$1.50M-37.7%
Q2 FY2025Jun 30, 2025$1.80M-19.6%
Q1 FY2025Mar 31, 2025$1.62M-31.2%
Q4 FY2024Dec 31, 2024$5.77M+161.5%
Q3 FY2024Sep 30, 2024$2.42M+12.1%
Q2 FY2024Jun 30, 2024$2.24M-5.5%
Q1 FY2024Mar 31, 2024$2.35M-15.8%
Q4 FY2023Dec 31, 2023$2.21M-29.7%
Q3 FY2023Sep 30, 2023$2.16M-8.2%
Q2 FY2023Jun 30, 2023$2.36M+15.6%
Q1 FY2023Mar 31, 2023$2.79M+54.7%
Q4 FY2022Dec 31, 2022$3.14M+80.0%
Q3 FY2022Sep 30, 2022$2.35M+49.1%
Q2 FY2022Jun 30, 2022$2.05M-10.9%
Q1 FY2022Mar 31, 2022$1.80M-22.0%
Q4 FY2021Dec 31, 2021$1.74M-17.4%
Q3 FY2021Sep 30, 2021$1.58M-19.3%
Q2 FY2021Jun 30, 2021$2.29M+8.4%
Q1 FY2021Mar 31, 2021$2.31M-23.5%
Q4 FY2020Dec 31, 2020$2.11M-50.3%
Q3 FY2020Sep 30, 2020$1.95M-44.1%
Q2 FY2020Jun 30, 2020$2.12M-34.4%
Q1 FY2020Mar 31, 2020$3.02M+8.4%
Q4 FY2019Dec 31, 2019$4.25M+91.2%
Q3 FY2019Sep 30, 2019$3.49M+64.2%
Q2 FY2019Jun 30, 2019$3.22M+38.4%
Q1 FY2019Mar 31, 2019$2.79M+79.2%
Q4 FY2018Dec 31, 2018$2.22M+15.8%
Q3 FY2018Sep 30, 2018$2.13M+15.3%
Q2 FY2018Jun 30, 2018$2.33M+8.5%
Q1 FY2018Mar 31, 2018$1.56M-23.3%
Q4 FY2017Dec 31, 2017$1.92M–
Q3 FY2017Sep 30, 2017$1.84M–
Q2 FY2017Jun 30, 2017$2.15M–
Q1 FY2017Mar 31, 2017$2.03M–

More Neuronetics figures

See a number that looks wrong?